U.S. Pharma Stock News

In recent weeks, Nu Holdings moved to broaden its footprint by securing new bank charters in Mexico, Brazil, and the U.S. while rolling out additional products such as a Brazilian private credit ETF and small-business services across Latin America. This push into full banking licenses and investment products signals Nu’s intent to deepen monetization, diversify revenue sources, and reinforce its position as a digital-first financial platform in the region. Next, we’ll examine how Nu’s...

Recently, several Wall Street firms including Keefe, Bruyette & Woods, Barclays, and JP Morgan reiterated their views on Anywhere Real Estate, highlighting its position in residential brokerage and related services. Together with televised commentary from Jim Cramer, these reactions underscore how divided professional and media opinions remain on the outlook for traditional real estate service providers. Next, we’ll explore how this mix of fresh analyst support and public skepticism may...

If you are wondering whether Bloom Energy is still worth pursuing after its huge run, or if the easy money has already been made, this article unpacks what the market might be getting right and wrong about the stock. The share price has cooled slightly in the very short term, slipping around 0.8% over the last week and 1.3% over the past month. However, that comes after a 280.1% year-to-date gain and a 267.0% increase over the last year. Behind those moves, investors have been reacting to a...

GrafTech International Ltd. ( NYSE:EAF ) shareholders would be excited to see that the share price has had a great...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Wondering if Ford Motor's stock is still a value play after its big run, or if you have already missed the sweet spot? This breakdown will help you decide whether it deserves a place in your portfolio. Ford is trading at $13.47 after slipping 1.3% over the last week, but that comes on the back of a 5.0% gain over the past month, a 39.6% jump year to date, and a 46.1% rise over the last year, nearly doubling over 5 years with a 99.7% total return. Recent headlines have focused on Ford's...

RXO (RXO) is back in focus after a string of cautious analyst updates and a negative outlook revision from S&P Global, all pointing to the same issue: margin pressure is getting harder to ignore. See our latest analysis for RXO. The market has been quick to price in those tightening margins, with RXO’s 7 day share price return of minus 9.6 percent and a year to date share price return of minus 42.7 percent underscoring fading momentum despite a recent 30 day share price rebound of 18.2...

Old National Bancorp (ONB) just pulled investors into a legal drama by suing Bell Bank and eight former employees over alleged coordinated resignations, trade secret misuse, and customer poaching at key Minnesota branches. See our latest analysis for Old National Bancorp. At around $23.35, Old National’s recent momentum looks constructive, with a 1 month share price return of 10.66 percent and a 1 year total shareholder return of 10.57 percent suggesting investors are cautiously rewarding its...

In its recently reported third quarter, Federated Hermes posted revenue growth of 14.9% year on year, beating analyst estimates by 5.5% and delivering a stronger-than-expected earnings performance. This upside surprise was powered by record net sales of equity funds and rising demand for the firm’s MDT equity and alternative quantitative strategies, underscoring investor appetite for its quantitative capabilities. Next, we’ll examine how this earnings beat, underpinned by record equity fund...

Cytokinetics has secured U.S. FDA approval for MYQORZO (aficamten) tablets to treat adults with symptomatic obstructive hypertrophic cardiomyopathy, its first approved medicine and one that comes with a boxed warning and a REMS program due to heart failure risk. The label’s flexible dosing, lack of mandatory drug–drug interaction monitoring, and supporting Phase 3 SEQUOIA-HCM data could meaningfully influence how cardiologists position MYQORZO against existing therapies in oHCM care. We’ll...

Bausch Health Companies Inc. has reported past results of its exchange offers, with Existing Senior Secured Notes tendered for up to US$1.60 billion in new 10.00% Senior Secured Notes due 2032 issued by subsidiary 1261229 B.C. Ltd. The very large US$2.69 billion of notes submitted by the early tender time highlights strong creditor participation in reshaping Bausch Health’s debt profile. We’ll now examine how this large-scale debt exchange, especially extending maturities to 2032, feeds into...

Joby Aviation (JOBY) has quietly traded higher this month, and that move is getting harder for investors to ignore. With shares up about 9% in the past month and 76% year to date, the market is clearly reassessing its long term air taxi story. See our latest analysis for Joby Aviation. That surge sits within a much bigger move, with a roughly 76% year to date share price return and an even stronger 3 year total shareholder return above 300%. This suggests momentum is building as investors...

Southern (SO) just secured a major green light in Georgia, where regulators unanimously approved Georgia Power’s plan to boost capacity to meet the AI-driven data center surge across the state. See our latest analysis for Southern. Despite the regulatory win, Southern’s recent share price return has cooled, with a roughly 9 percent 3 month pullback and softer 1 month performance, even as its 5 year total shareholder return of about 72 percent signals durable, long term compounding. If this AI...

Earlier this month, Revvity, Inc. introduced Signals Xynthetica, an AI Models-as-a-Service offering within its Revvity Signals platform to support AI-augmented molecular and materials design by unifying in-silico generation, predictive modeling, and experimental validation in a governed environment. An interesting angle is that Signals Xynthetica embeds AI models directly into real-world lab workflows, linking predictions with wet-lab outcomes to create a continuously learning discovery loop...

As the U.S. market experiences a resurgence with major stock indexes closing sharply higher for the second consecutive day, small-cap stocks are gaining attention amid this renewed risk appetite. In this dynamic environment, identifying promising small-cap opportunities involves looking at companies with solid fundamentals and potential growth catalysts that align well with current market trends.

J.B. Hunt Transport Services (JBHT) heads into its upcoming Q4 earnings with expectations running higher than usual, following a strong Q3 and a clear uptick in bullish options activity around the stock. See our latest analysis for J.B. Hunt Transport Services. The strong Q3 surprise and recent bullish options flow have helped fuel a sharp rebound. J.B. Hunt’s roughly 50 percent 3 month share price return signals that momentum is clearly building rather than fading. If this kind of move has...

As the U.S. stock market experiences a resurgence with major indexes posting gains, driven by a rally in tech stocks, investors are increasingly looking for opportunities that may be undervalued. In this environment of renewed risk appetite and shifting sector performances, identifying stocks that offer strong fundamentals at attractive valuations becomes crucial for those seeking potential value in their portfolios.

Coherent Corp. ( NYSE:COHR ) shares have continued their recent momentum with a 33% gain in the last month alone. The...

As the U.S. stock market experiences a resurgence, with major indexes like the S&P 500 and Nasdaq posting weekly gains amid a tech rally, investor confidence appears to be on the rise. In such an environment, growth companies with high insider ownership can signal strong internal belief in their long-term potential, making them attractive considerations for those looking to align with management's vision.

As of December 19, 2025, major stock indexes in the United States have shown a notable upswing, with the tech-heavy Nasdaq and benchmark S&P 500 posting weekly gains amid a continued rally in technology shares. This positive momentum in broader markets can create an intriguing backdrop for exploring investment opportunities across various sectors. Penny stocks, while often considered speculative due to their lower price points and smaller company profiles, remain relevant as they can offer...

Key Insights Insiders appear to have a vested interest in Freedom Holding's growth, as seen by their sizeable ownership...

Alto Ingredients, Inc. ( NASDAQ:ALTO ) shares have continued their recent momentum with a 41% gain in the last month...

Potential 374Water Inc. ( NASDAQ:SCWO ) shareholders may wish to note that the Interim President, Stephen Jones...

Opera Limited's ( NASDAQ:OPRA ) investors are due to receive a payment of $0.39 per share on 14th of January. The...